Dunn Edmund
Principal Accounting Officer
CIK: 1989401
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | S | 139 | $17.96 | $2,496.44 | View Details Filing |
| Mar 2, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | M | 536 | $13.41 | $7,187.76 | View Details Filing |
| Mar 2, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | S | 536 | $17.50 | $9,380.00 | View Details Filing |
| Mar 2, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | M | 536 | $0.00 | $0.00 | View Details Filing |
| Feb 27, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | M | 25,164 | $13.41 | $337,449.24 | View Details Filing |
| Feb 27, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | S | 25,164 | $18.10 | $455,506.15 | View Details Filing |
| Feb 27, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | M | 25,164 | $0.00 | $0.00 | View Details Filing |
| Jan 5, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | S | 1,039 | $15.17 | $15,761.63 | View Details Filing |